BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16925115)

  • 1. Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.
    Tempestini A; Caciagli B; Morganti M; Witort E; Nobili S; Papucci L; Schiavone N; Donnini M; Landini I; Lapucci A; Perna F; Lulli M; Mazzei T; Sobrero A; Mini E; Capaccioli S
    Oncol Res; 2005; 16(3):143-56. PubMed ID: 16925115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
    J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
    Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
    Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
    De Angelis PM; Kravik KL; Tunheim SH; Haug T; Reichelt WH
    Mol Cancer; 2004 Apr; 3():11. PubMed ID: 15109396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil.
    Przybyła T; Sakowicz-Burkiewicz M; Maciejewska I; Bielarczyk H; Pawełczyk T
    Acta Biochim Pol; 2017; 64(2):315-322. PubMed ID: 28510612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
    Yang C; Pan Y; Deng SP
    BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of pemetrexed-resistant non-small cell lung cancer cell lines.
    Zhang D; Ochi N; Takigawa N; Tanimoto Y; Chen Y; Ichihara E; Hotta K; Tabata M; Tanimoto M; Kiura K
    Cancer Lett; 2011 Oct; 309(2):228-35. PubMed ID: 21742432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor activity of capecitabine in combination with irinotecan.
    Cao S; Durrani FA; Rustum YM
    Clin Colorectal Cancer; 2005 Jan; 4(5):336-43. PubMed ID: 15663838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels.
    Yan D; Zheng X; Tu L; Jia J; Li Q; Cheng L; Wang X
    Mol Med Rep; 2015 Jan; 11(1):295-302. PubMed ID: 25352209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase.
    Fukushima M; Sakamoto K; Ohshimo H; Nakagawa F; Taguchi T
    Oncol Rep; 2010 Oct; 24(4):835-42. PubMed ID: 20811661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2
    Fang Y; Yang C; Zhang L; Wei L; Lin J; Zhao J; Peng J
    Biomed Res Int; 2019; 2019():5953619. PubMed ID: 31662984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative effects of ZD0473 (AMD473) in combination with 5-fluorouracil or SN38 in human colorectal cancer cell lines.
    Plasencia C; Abad A; Martinez-Balibrea E; Taron M
    Invest New Drugs; 2004 Nov; 22(4):399-409. PubMed ID: 15292710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
    Zhu H; Guo W; Zhang L; Davis JJ; Teraishi F; Wu S; Cao X; Daniel J; Smythe WR; Fang B
    Mol Cancer Ther; 2005 Mar; 4(3):451-6. PubMed ID: 15767554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo.
    Guichard S; Arnould S; Hennebelle I; Bugat R; Canal P
    Anticancer Drugs; 2001 Oct; 12(9):741-51. PubMed ID: 11593056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma.
    Toriumi F; Kubota T; Saikawa Y; Yoshida M; Otani Y; Watanabe M; Kumai K; Kitajima M
    Anticancer Res; 2004; 24(4):2455-63. PubMed ID: 15330198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of chemotherapeutic agents and cytokines on the expression of 5-fluorouracil-associated enzymes in human colon cancer cell lines.
    Miyazaki K; Shibahara T; Sato D; Uchida K; Suzuki H; Matsui H; Yanaka A; Nakahara A; Matsuzaki Y
    J Gastroenterol; 2006 Feb; 41(2):140-50. PubMed ID: 16568373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules.
    Aschele C; Sobrero A; Faderan MA; Bertino JR
    Cancer Res; 1992 Apr; 52(7):1855-64. PubMed ID: 1532346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.